A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia
Clinical trial NCT03965091 · TERMINATED
Trial details
- NCT number
- NCT03965091
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-31
- Primary completion
- 2022-01-19
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.